BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8856022)

  • 1. Polygenic control of antibody production and correlation with vaccine induced resistance to rabies virus in high and low antibody responder mice.
    De Franco M; Massa S; Vassão RC; Siqueira M; Sant'Anna OA
    Arch Virol; 1996; 141(8):1397-406. PubMed ID: 8856022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabies virus immunity in genetically selected high- and low-responder lines of mice.
    Nilsson MR; Sant'anna OA; Siqueira M; Nilsson TT; Gennari M
    Infect Immun; 1979 Jul; 25(1):23-6. PubMed ID: 478636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG modulation of delayed type hypersensitivity, humoral response and acquired resistance after rabies vaccination.
    Tsiang H; Blancou J; Lagrange PH
    Arch Virol; 1981; 69(3-4):167-76. PubMed ID: 7295038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice.
    Lafon M; Bourhy H; Sureau P
    Vaccine; 1988 Aug; 6(4):362-8. PubMed ID: 2461007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro.
    Lodmell DL; Esposito JJ; Ewalt LC
    J Virol; 1993 Oct; 67(10):6080-6. PubMed ID: 8371354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
    Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
    Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabies infection and specific effect of vaccination in mice selected for high and low immunobiological parameters.
    Queiroz-da-Silva LH; De-Franco M; Sant'Anna OA
    Braz J Med Biol Res; 1997 Nov; 30(11):1309-13. PubMed ID: 9532239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
    Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
    J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant replication-defective adenovirus based rabies vaccine].
    Li WH; Zhang Y; Wang SH; Liu L; Yang F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
    Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination challenge studies with variants of street rabies virus isolated in Nigeria.
    Okoh AE; Umoh JU; Ezeokoli CD; Addo PB
    Vaccine; 1988 Feb; 6(1):19-24. PubMed ID: 3354253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of systemic injection of rabies immunoglobulin in rabies vaccination.
    Wu W; Liu S; Yu P; Tao X; Lu X; Yan J; Wang Q; Zhang Z; Zhu W
    Arch Virol; 2017 Jun; 162(6):1701-1703. PubMed ID: 28188373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody.
    Dietzschold B; Tollis M; Rupprecht CE; Celis E; Koprowski H
    J Infect Dis; 1987 Nov; 156(5):815-22. PubMed ID: 3655404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complement-fixing rabies antibodies in mice vaccinated and posteriorly challenged].
    Oliveira LH; Andrade CM; Reis W
    An Microbiol (Rio J); 1980; 25():135-47. PubMed ID: 6982627
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune responses of mice to inactivated rabies vaccine administered orally: potentiation by Quillaja saponin.
    Maharaj I; Froh KJ; Campbell JB
    Can J Microbiol; 1986 May; 32(5):414-20. PubMed ID: 3719460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic control of serum neutralizing-antibody response to rabies vaccination and survival after a rabies challenge infection in mice.
    Templeton JW; Holmberg C; Garber T; Sharp RM
    J Virol; 1986 Jul; 59(1):98-102. PubMed ID: 3086569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune efficacy of rabies virus glycoprotein expressed by baculovirus vector].
    Chen Q; Zhang SF; Liu Y; Fu YH; Sun CL; Yang Y; Gong T; Song FF; Hu RL
    Bing Du Xue Bao; 2012 Sep; 28(5):501-5. PubMed ID: 23233923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Interleukin-7 Extends the Humoral Immune Response Induced by Rabies Vaccination.
    Li Y; Zhou M; Luo Z; Zhang Y; Cui M; Chen H; Fu ZF; Zhao L
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.